Day: December 3, 2023

IZEA Announces Acquisition of Australian Influencer Marketing Leader Hoozu

IZEA Announces Acquisition of Australian Influencer Marketing Leader Hoozu

Written by Customer Service on . Posted in Public Companies.

Company Continues Global Expansion Within APAC Region IZEA Announces Acquisition of Australian Influencer Marketing Leader Hoozu Company Continues Global Expansion Within APAC Region ORLANDO, Fla., Dec. 03, 2023 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands and agencies, announced today it has acquired Hoozu, Australia’s leading influencer marketing company headquartered in Sydney. The company serves a roster of the region’s most innovative brands, including Bunnings, Emma Sleep, Super Cheap Auto, and Ryobi. In addition to its core services, Hoozu’s talent management division, called Huume, represents creators in the Australian market. IZEA has been at the forefront of the creator economy since 2006, when...

Continue reading

5E Advanced Materials Announces an Extension to Standstill Agreement

5E Advanced Materials Announces an Extension to Standstill Agreement

Written by Customer Service on . Posted in Public Companies.

Agreement with Lender to extend timeline of the on-going Standstill Agreement until December 6, 2023, at 5PM PST HESPERIA, Calif., Dec. 03, 2023 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas (Fort Cady) Complex, today announced that it has extended its existing Standstill Agreement (see release dated November 9, 2023) with BEP Special Situations IV, LLC (“Lender”), its primary lender and the holder of the Company’s senior secured convertible notes until December 6, 2023 at 5pm PST. About 5E Advanced Materials, Inc. 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) is focused on becoming a vertically integrated global leader and supplier of boron specialty and advanced...

Continue reading

Hexagon Purus receives order to deliver hydrogen distribution systems to a leading player within the green hydrogen ecosystem  

Hexagon Purus receives order to deliver hydrogen distribution systems to a leading player within the green hydrogen ecosystem  

Written by Customer Service on . Posted in Public Companies.

(Oslo, 3 December 2023) Hexagon Purus, a world leading manufacturer of zero emission mobility and infrastructure solutions, has received purchase orders for the delivery of hydrogen distribution systems to a leading player within the green hydrogen ecosystem, worth approximately EUR 9.6 million. Hexagon Purus’ hydrogen distribution systems, including its type 4 hydrogen cylinders, will be used to deliver green hydrogen to industrial applications in Central Europe. Driving Energy Transformation “There is a growing need to move hydrogen around, and our distribution systems are significantly more cost-effective than traditional metal tube transportation solutions. We expect demand for our systems to gain further momentum as green hydrogen increasingly becomes part of the hydrogen mix”, says Michael Kleschinski, EVP Hydrogen Infrastructure...

Continue reading

Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 2023

Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 2023

Written by Customer Service on . Posted in Public Companies.

MCLA-129 in combination with chemotherapy in 2L+ EGFRm NSCLC planned to initiate 1Q24 UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, 2023 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced updated interim clinical data on MCLA-129 from ongoing expansion cohorts in non-small cell lung cancer (NSCLC) and in previously treated head and neck squamous cell carcinoma (HNSCC) were presented at the European Society for Medical Oncology (ESMO) Asia Congress 2023. “MCLA-129 is a very active drug in EGFRm NSCLC and we’re planning a focused investment to evaluate MCLA-129 in combination with chemotherapy, which we expect to start early in 2024,” said Bill Lundberg...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.